These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 26002964)

  • 1. Lenalidomide augments actin remodeling and lowers NK-cell activation thresholds.
    Lagrue K; Carisey A; Morgan DJ; Chopra R; Davis DM
    Blood; 2015 Jul; 126(1):50-60. PubMed ID: 26002964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers.
    Wu L; Parton A; Lu L; Adams M; Schafer P; Bartlett JB
    Cancer Immunol Immunother; 2011 Jan; 60(1):61-73. PubMed ID: 20848094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy.
    Brown AC; Oddos S; Dobbie IM; Alakoskela JM; Parton RM; Eissmann P; Neil MA; Dunsby C; French PM; Davis I; Davis DM
    PLoS Biol; 2011 Sep; 9(9):e1001152. PubMed ID: 21931537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human natural killer cells expressing the memory-associated marker CD45RO from tuberculous pleurisy respond more strongly and rapidly than CD45RO- natural killer cells following stimulation with interleukin-12.
    Fu X; Liu Y; Li L; Li Q; Qiao D; Wang H; Lao S; Fan Y; Wu C
    Immunology; 2011 Sep; 134(1):41-9. PubMed ID: 21711347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The immunostimulatory effect of lenalidomide on NK-cell function is profoundly inhibited by concurrent dexamethasone therapy.
    Hsu AK; Quach H; Tai T; Prince HM; Harrison SJ; Trapani JA; Smyth MJ; Neeson P; Ritchie DS
    Blood; 2011 Feb; 117(5):1605-13. PubMed ID: 20978269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.
    Campbell KS; Cohen AD; Pazina T
    Front Immunol; 2018; 9():2551. PubMed ID: 30455698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect.
    Benson DM; Bakan CE; Zhang S; Collins SM; Liang J; Srivastava S; Hofmeister CC; Efebera Y; Andre P; Romagne F; Bléry M; Bonnafous C; Zhang J; Clever D; Caligiuri MA; Farag SS
    Blood; 2011 Dec; 118(24):6387-91. PubMed ID: 22031859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant.
    Borhani K; Bamdad T; Hashempour T
    Iran J Immunol; 2017 Jun; 14(2):151-158. PubMed ID: 28630385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells.
    Dauguet N; Fournié JJ; Poupot R; Poupot M
    Cell Immunol; 2010; 264(2):163-70. PubMed ID: 20621290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Characterisation and Analysis of the Soluble NKG2D Ligand Repertoire Detected in Umbilical Cord Blood Plasma.
    Cox ST; Danby R; Hernandez D; Laza-Briviesca R; Pearson H; Madrigal JA; Saudemont A
    Front Immunol; 2018; 9():1282. PubMed ID: 29963042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shedding of CD16 disassembles the NK cell immune synapse and boosts serial engagement of target cells.
    Srpan K; Ambrose A; Karampatzakis A; Saeed M; Cartwright ANR; Guldevall K; De Matos GDSC; Önfelt B; Davis DM
    J Cell Biol; 2018 Sep; 217(9):3267-3283. PubMed ID: 29967280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-induced cytotoxicity in human multiple myeloma: clinical implications.
    Tai YT; Li XF; Catley L; Coffey R; Breitkreutz I; Bae J; Song W; Podar K; Hideshima T; Chauhan D; Schlossman R; Richardson P; Treon SP; Grewal IS; Munshi NC; Anderson KC
    Cancer Res; 2005 Dec; 65(24):11712-20. PubMed ID: 16357183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions.
    Wang Z; Guan D; Wang S; Chai LYA; Xu S; Lam KP
    Front Immunol; 2020; 11():202. PubMed ID: 32153568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD94/NKG2A inhibits NK cell activation by disrupting the actin network at the immunological synapse.
    Masilamani M; Nguyen C; Kabat J; Borrego F; Coligan JE
    J Immunol; 2006 Sep; 177(6):3590-6. PubMed ID: 16951318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of natural killer cells by hepatitis C virus particles in vitro.
    Farag MM; Weigand K; Encke J; Momburg F
    Clin Exp Immunol; 2011 Sep; 165(3):352-62. PubMed ID: 21682720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of natural killer cell effector functions through lenalidomide/dasatinib and their combined effects against multiple myeloma cells.
    Jungkunz-Stier I; Zekl M; Stühmer T; Einsele H; Seggewiss-Bernhardt R
    Leuk Lymphoma; 2014 Jan; 55(1):168-76. PubMed ID: 23573828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Super-resolution imaging of remodeled synaptic actin reveals different synergies between NK cell receptors and integrins.
    Brown AC; Dobbie IM; Alakoskela JM; Davis I; Davis DM
    Blood; 2012 Nov; 120(18):3729-40. PubMed ID: 22966166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
    Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
    J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of human NK cell reactivity using latex beads coated with defined amounts of antibodies.
    Dorsch M; Urlaub D; Bönnemann V; Bröde P; Sandusky M; Watzl C
    Eur J Immunol; 2020 May; 50(5):656-665. PubMed ID: 32027754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.